...
首页> 外文期刊>The Journal of Immunology: Official Journal of the American Association of Immunologists >Absence of allograft icam-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.
【24h】

Absence of allograft icam-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection.

机译:同种异体移植物icam-1的缺失减弱了同种异体抗原特异性T细胞的启动,但未引发启动的T细胞向移植物中的运输,以介导急性排斥反应。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The expression and function of ICAM-1 are critical components in the initiation and elicitation of many T cell-mediated responses. Whether ICAM-1 expression is required on the T cells or on the APC during T cell priming remains unclear. To address this issue in alloantigen-specific T cell activation, the priming and function of T cells in response to heart allografts from MHC-mismatched wild-type vs ICAM-1(-/-) donors were tested. Wild-type C57BL/6 (H-2(b)) heart allografts were rejected by A/J (H-2(a)) recipients on days 7-9, whereas B6.ICAM-1(-/-) allografts survived until days 18-23 post-transplant. On day 7 post-transplant, infiltrating macrophages and CD4(+) and CD8(+) T cells in the ICAM-1(-/-) allografts were 20-30% those observed in the wild-type allografts. ELISPOT analyses indicated that the number of alloantigen-specific T cells producing IFN-gamma from recipients of ICAM-1-deficient grafts was 60% lower than that from recipients of wild-type allografts. On day 16 post-transplant, these numbers did not markedly increase in ICAM-1-deficient allograft recipients. Consistent with the reduced priming of alloreactive T cells, isolated dendritic cells from ICAM-1(-/-) mice stimulated allogeneic T cell proliferation poorly compared with wild-type dendritic cells. When A/J mice were primed with wild-type dendritic cells and then received wild-type or ICAM-1-deficient heart allografts 3 days later, the primed recipients rejected the wild-type and ICAM-1(-/-) allografts on days 5-6 post-transplant. These results indicate that optimal priming of alloreactive T cells requires allograft expression of ICAM-1, but, once primed, recipient T cell infiltration into the allograft is independent of graft ICAM-1 expression.
机译:ICAM-1的表达和功能是许多T细胞介导的反应的起始和引发的关键组成部分。在T细胞启动过程中,是否需要在T细胞上或APC上需要ICAM-1表达。为了解决同种异体抗原特异性T细胞活化中的这个问题,测试了MHC不匹配的野生型vs ICAM-1(-/-)供体对心脏同种异体移植T细胞的启动和功能。野生型C57BL / 6(H-2(b))心脏同种异体移植在7-9天被A / J(H-2(a))接受者拒绝,而B6.ICAM-1(-/-)同种异体存活。直到移植后18-23天。移植后第7天,ICAM-1(-/-)同种异体移植物中的浸润巨噬细胞以及CD4(+)和CD8(+)T细胞占野生型同种异体移植物中20-30%。 ELISPOT分析表明,来自ICAM-1缺陷型受体的同种异体抗原特异性T细胞产生IFN-γ的数量比野生型同种异体的T细胞低60%。移植后第16天,在缺乏ICAM-1的同种异体移植受者中,这些数字并未明显增加。与降低同种反应性T细胞的启动反应一致,与野生型树突状细胞相比,从ICAM-1(-/-)小鼠分离的树突状细胞刺激的同种异体T细胞增殖能力较差。当A / J小鼠接受野生型树突状细胞的灌注,然后在3天后接受野生型或ICAM-1缺陷的心脏同种异体移植时,接受灌注的受体拒绝接受野生型和ICAM-1(-/-)同种异体移植。移植后5-6天。这些结果表明,同种异体反应性T细胞的最佳引发需要同种异体移植物表达ICAM-1,但是一旦引发,受体T细胞向同种异体移植物中的浸润与移植ICAM-1表达无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号